BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33138374)

  • 1. Experimental and Computational Druggability Exploration of the 14-3-3ζ/SOS1pS
    Ballone A; Picarazzi F; Prosser C; Davis J; Ottmann C; Mori M
    J Chem Inf Model; 2020 Dec; 60(12):6555-6565. PubMed ID: 33138374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benchmark Study Based on 2P2I
    Wang Z; Kang Y; Li D; Sun H; Dong X; Yao X; Xu L; Chang S; Li Y; Hou T
    J Phys Chem B; 2018 Mar; 122(9):2544-2555. PubMed ID: 29420886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational probing protein-protein interactions targeting small molecules.
    Wang YC; Chen SL; Deng NY; Wang Y
    Bioinformatics; 2016 Jan; 32(2):226-34. PubMed ID: 26415726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging roles of allosteric modulators in the regulation of protein-protein interactions (PPIs): A new paradigm for PPI drug discovery.
    Ni D; Lu S; Zhang J
    Med Res Rev; 2019 Nov; 39(6):2314-2342. PubMed ID: 30957264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network analysis and in silico prediction of protein-protein interactions with applications in drug discovery.
    Murakami Y; Tripathi LP; Prathipati P; Mizuguchi K
    Curr Opin Struct Biol; 2017 Jun; 44():134-142. PubMed ID: 28364585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecules modulation of 14-3-3 protein-protein interactions.
    Mori M; Vignaroli G; Botta M
    Drug Discov Today Technol; 2013 Dec; 10(4):e541-7. PubMed ID: 24451646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based assessment and druggability classification of protein-protein interaction sites.
    Alzyoud L; Bryce RA; Al Sorkhy M; Atatreh N; Ghattas MA
    Sci Rep; 2022 May; 12(1):7975. PubMed ID: 35562538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomic analysis of protein-protein interfaces with known inhibitors: the 2P2I database.
    Bourgeas R; Basse MJ; Morelli X; Roche P
    PLoS One; 2010 Mar; 5(3):e9598. PubMed ID: 20231898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational identification of non-synonymous polymorphisms within regions corresponding to protein interaction sites.
    Skrlj B; Kunej T
    Comput Biol Med; 2016 Dec; 79():30-35. PubMed ID: 27744178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development.
    Harati S; Cooper LA; Moran JD; Giuste FO; Du Y; Ivanov AA; Johns MA; Khuri FR; Fu H; Moreno CS
    PLoS One; 2017; 12(1):e0170339. PubMed ID: 28118365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing structural adaptivity at PPI interfaces with small molecules.
    Wilson CG; Arkin MR
    Drug Discov Today Technol; 2013 Dec; 10(4):e501-8. PubMed ID: 24451641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Druggability assessment of protein-protein interfaces.
    Wanner J; Fry DC; Peng Z; Roberts J
    Future Med Chem; 2011 Dec; 3(16):2021-38. PubMed ID: 22098351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-Protein Interaction Inhibition (2P2I)-Oriented Chemical Library Accelerates Hit Discovery.
    Milhas S; Raux B; Betzi S; Derviaux C; Roche P; Restouin A; Basse MJ; Rebuffet E; Lugari A; Badol M; Kashyap R; Lissitzky JC; Eydoux C; Hamon V; Gourdel ME; Combes S; Zimmermann P; Aurrand-Lions M; Roux T; Rogers C; Müller S; Knapp S; Trinquet E; Collette Y; Guillemot JC; Morelli X
    ACS Chem Biol; 2016 Aug; 11(8):2140-8. PubMed ID: 27219844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State of the art in protein-protein interactions within the fungi kingdom.
    Santos TG; Silva KS; Lima RM; Silva LC; Pereira M
    Future Microbiol; 2023 Nov; 18():1119-1131. PubMed ID: 37540069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of hydrogen/deuterium exchange or chemical cross-linking techniques with mass spectrometry: mapping of human 14-3-3ζ homodimer interface.
    Haladová K; Mrázek H; Ječmen T; Halada P; Man P; Novák P; Chmelík J; Obšil T; Šulc M
    J Struct Biol; 2012 Jul; 179(1):10-7. PubMed ID: 22580067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the Druggablility on the Interface of the Protein-Protein Interaction and Its Allosteric Regulation Mechanism on the Drug Screening for the CXCR4 Homodimer.
    Shen L; Yuan Y; Guo Y; Li M; Li C; Pu X
    Front Pharmacol; 2019; 10():1310. PubMed ID: 31787895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational methods for predicting protein-protein interactions.
    Pitre S; Alamgir M; Green JR; Dumontier M; Dehne F; Golshani A
    Adv Biochem Eng Biotechnol; 2008; 110():247-67. PubMed ID: 18202838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generating Potential Protein-Protein Interaction Inhibitor Molecules Based on Physicochemical Properties.
    Ohue M; Kojima Y; Kosugi T
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantum Molecular Dynamics, Topological, Group Theoretical and Graph Theoretical Studies of Protein-Protein Interactions.
    Balasubramanian K; Gupta SP
    Curr Top Med Chem; 2019; 19(6):426-443. PubMed ID: 30836919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?
    Cierpicki T; Grembecka J
    Immunol Rev; 2015 Jan; 263(1):279-301. PubMed ID: 25510283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.